Oliver Wyman Health Innovation Summit 2021

Aparna Abburi has more than two decades of experience across a full spectrum of payer businesses, including group commercial (large, mid and small), individual insurance, managed Medicaid, Long-Term Services and Support (LTSS), duals and Medicare. In her current role, Aparna drives strategy, operational and financial performance, and overall growth of Cigna’s Medicare business (Medicare Advantage, Government Pharmacy and Cigna Supplemental Benefits), which is one of the company’s key strategic enterprise growth priorities. She also leads CareAllies, which works with payers, physician practices and delivery systems to accelerate their transition to value-based care. Aparna holds a master’s degree in business administration (MBA) from the University of Chicago and a bachelor’s degree in engineering from the Birla Institute of Technology and Science in India. She resides in the Chicagoland area with her husband and two sons.

Faiz Ahmad is CEO for Optum Direct-to-Consumer (DTC). He leads the Optum DTC business including our virtual pharmacy business, providing consumers – with or without a benefit plan – access to an online marketplace and a consumer pharmacy experience, making pharmacy care more accessible to those served. Faiz joined UnitedHealth Group in 2019 and has over 20 years of retail, digital commerce and product marketing experience. Prior to joining UnitedHealth Group, Faiz was global leader of Online Retail at Apple, where he was responsible for leading one of the top five largest digital businesses globally. There he was also responsible for the Apple Store app, Apple.com, global retail customer service, consumer payments and Retail Market Development teams. Prior to Apple, Faiz worked at Delta in a variety of roles and organization from technology to strategy to Marketing to Digital Commerce. Faiz holds a Bachelor of Engineering degree from the Mangalore University, India and an MBA from Emory University’s Goizueta Business School. He lives in the Bay Area with his wife and their twins.

Bernard (Bernie) Banks is a noted expert on the subjects of leadership and organizational change. Currently, he is the Associate Dean for Leadership Development and Inclusion (and a Clinical Professor of Management) at Northwestern University’s Kellogg School of Management. As an Associate Dean, Bernie is accountable for leader development integration across the school’s global portfolio of degree programs. He also leads the institution’s diversity, equity, and inclusion initiatives. Bernie retired from the US Army with the rank of Brigadier General after having successfully led West Point’s Department of Behavioral Sciences & Leadership for his final military assignment. In addition to having studied leadership extensively, he has led multiple organizations ranging in size from 10 to over 3000 people. In 1995, Bernie was selected from over 40,000 officers to receive the Army's top award for entry-level managers (General Douglas MacArthur Leadership Award). In 2006, the Apache Helicopter unit he was leading in South Korea was designated as the number one US Army Apache Helicopter unit globally. Bernie is a broadly educated scholar-practitioner. He attained his bachelor’s degree from West Point and a Ph.D. in social-organizational psychology from Columbia University. Bernie also holds master’s degrees from Northwestern, Columbia, and Harvard Universities. Bernie has published work in a variety of outlets (e.g., Harvard Business Review, Military Psychology, and New York Times). Furthermore, he has worked extensively with organizations across all sectors concerning their leader development efforts (e.g., Morgan Stanley, Procter and Gamble, Mercedes Benz, Microsoft, IBM, 7-Eleven, Goldman Sachs). An active member of several civic and professional organizations (e.g., The Chicago Club, The Economic Club of Chicago), Bernie is deeply invested in his community.

Dan Barouch received his PhD in immunology from Oxford University and his MD from Harvard Medical School. He is currently the William Bosworth Castle Professor of Medicine and Professor of Immunology at Harvard Medical School, Director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center, a member of the Ragon Institute of MGH, MIT, and Harvard, and part of the Bill & Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery. His laboratory focuses on studying the immunology and virology of HIV-1 infection and developing novel vaccine and eradication strategies. His group has also applied their vaccine expertise to preclinical and clinical studies of other infectious diseases of global significance, including Zika virus, tuberculosis, and most recently SARS-CoV-2. His recent work contributed to the development of the single-shot Johnson & Johnson COVID-19 vaccine, which is now being rolled out in the United States and throughout the world. He was elected to the National Academy of Medicine in 2020.

Richard Clarke is the Chief Analytics Officer at Highmark Health. He focuses on delivering innovative data and advanced analytic solutions that fulfill Highmark Health’s mission of creating a remarkable health experience, freeing people to be their best. Richard arrived at Highmark in 2016 to assume the role of Vice President, Advanced Analytics and Reporting. Prior to that time, he was at McKinsey & Company for 9 years. While at Highmark, Richard has led several Analytics teams as well as Product, Clinical Services, and Human Centered Design. In 2020, he moved into the Chief Analytics Officer role, overseeing all Data and Analytics for Highmark Health. Richard holds a B.S. in Neuroscience from Allegheny College and a Ph.D. in Neuroscience from the Center for the Neural Basis of Cognition (CNBC), a joint program between CMU and the University of Pittsburgh.

Sandra Clarke is EVP and CFO at Blue Shield of California, a tax-paying nonprofit health plan with over $20 billion in annual revenue serving more than 4 million members in the state’s commercial, individual and government markets. She oversees the company’s financial strategy, actuarial functions and financial operations in addition to leading Enterprise Process Transformation, focused on transforming the member experience while reducing administrative expense. Sandra is also responsible for Corporate Development, where she plays a senior role in devising and enacting Blue Shield’s strategies to support growth and realize the company’s mission to transform healthcare. Sandra has demonstrated her ability to improve operations in global businesses with over 25 years of experience directing world-wide financial organizations spanning an array of critical industries. Prior to joining Blue Shield in 2018, she served as Senior Vice President and Chief Financial Officer of Daiichi Sankyo, Inc., the United States subsidiary of Tokyo-based Daiichi Sankyo Co., Ltd., which develops and markets a range of pharmaceuticals. Sandra also held executive finance roles at Philips Healthcare as Chief Financial Officer of its North & South America Commercial Group and at Siemens Water Technologies Group, where she was Vice President of Finance and Controller. She has a Master of Science in Healthcare Law from Seton Hall University School of Law, a Master of Science in Accounting from Bentley University, and a Bachelor of Science in Finance from the Massachusetts Institute of Technology. She was named by San Francisco Business Times as one of “The Most Influential Women in Bay Area Business 2019.”

Michelle Conger joined OSF HealthCare in 1994. From that time, she has served the OSF Healthcare System with growing responsibility at both the local and enterprise levels. Michelle has served as the Senior Vice President of Performance Improvement where she worked in collaboration with senior leadership to develop, design, and strategically manage the portfolio of improvement projects and opportunities based on OSF’s business strategy. In 2010, she began serving in her current role as Senior Vice President, Chief Strategy Officer for OSF Healthcare System. As the Chief Strategy Officer, Michelle has the responsibility for the development of system wide strategy, growth and business development plans, marketing and communications and innovation. In 2019 in addition to her role as CSO she became the first CEO of OSF OnCall, OSF’s digital health hub. This responsibly includes the execution of digital strategy, virtual care platforms and on demand care models. Her professional accomplishments also include achieving a Six Sigma black belt (2002) and Six Sigma master black belt (2003). Michelle holds an MSW from the University of Illinois Champaign Urbana.

Rushika Fernandopulle, MD, MPP, is a practicing physician and co-founder and CEO of Iora Health, a venture backed, national de-novo primary care group based in Boston MA. He started Iora with the vision to transform healthcare. He was the first Executive Director of the Harvard Interfaculty Program for Health Systems Improvement, and Managing Director of the Clinical Initiatives Center at the Advisory Board Company. He is a member of the Albert Schweitzer, Ashoka, Aspen, and Salzburg Global Fellowships, and is co-author or editor of several publications including Health Care Policy, a textbook for physicians and medical students, and Uninsured in America: Life and Death in the Land of Opportunity. He serves on the staff at the Massachusetts General Hospital, on the faculty of Harvard Medical School, and on the boards of Families USA and the Schwartz Center for Compassionate Care. He earned his AB, MD, and MPP (Masters in Public Policy) from Harvard University, and completed his clinical training at the University of Pennsylvania and the Massachusetts General Hospital. He enjoys golf, good wine, skiing, travel, and spending time with his wife, three daughters and loveable, but poorly behaved, dog.

Niyum Gandhi is the Chief Financial Officer and Treasurer at Mass General Brigham. His responsibilities include financial oversight of $14 billion in operations with assets of approximately $21 billion, and management within the areas of Corporate Finance, Managed Care, Real Estate and Treasury. Prior to joining Mass General Brigham in 2021, Niyum served as the Chief Financial Officer and Chief Population Health Officer at the Mount Sinai Health System in New York. In addition to overseeing the financial operations of organization’s eight hospitals and the Icahn School of Medicine, he built Mount Sinai’s clinically integrated network, direct-to-employer business unit and consumer digital function in his role leading population health and consumer solutions. Before his tenure at Mount Sinai, Niyum was a Partner in the Health and Life Sciences consulting practice of Oliver Wyman, a global management consulting firm, where he focused on financial planning, value-based health care, and transformation strategies for hospitals, physician groups, and health plans. Niyum holds an A.B. in economics from Harvard University.

Graham Gardner, MD, is the Co-founder and CEO of Kyruus where he has led the development and commercialization of the company’s market-leading patient access platform that now serves over 300,000 providers and 700 hospitals across the United States. Prior to Kyruus, Graham was a Venture Executive at Highland Capital Partners where he co-founded Generation Health, a genetic benefit management company that facilitates optimal utilization of genetic testing, and served as the company’s Chief Medical Officer through its acquisition by CVS Caremark. Graham completed his clinical training in internal medicine and cardiology at Beth Israel Deaconess Medical Center and Harvard Medical School, where he also served as Chief Medical Resident. Graham completed his BA and MD degrees at Brown University and earned an MBA from Harvard Business School. Outside of Kyruus, he currently serves as an advisor to the Innovation & Digital Health Accelerator at Boston Children’s Hospital.

Robin Glass is President at Grand Rounds Health and Doctor On Demand. She has spent over 20 years innovating and growing companies in the healthcare space. Prior to her current role, she drove growth and ensured successful partnerships at Evolent as Chief Customer Officer. Prior to Evolent Health, she was the Director of Strategic Accounts at Walgreens in the health and wellness division, employer segment. Glass received her MBA from Harvard Business School and her MPA from the Harvard Kennedy School of Government.

Marc Harrison, MD, president and CEO of Intermountain Healthcare, is a pediatric critical care physician with a proven track record as a top operations executive on a global scale. He is a national and international thought leader on transformation and innovation—ranking in Fortune Magazine’s Top 50 World’s Greatest Leaders in 2019. He also ranked second among Modern Healthcare’s Most Influential Physician Executives and Leaders and tied for second on its list of the 100 Most Influential People in Healthcare in 2018. Marc embraces strategic partnerships and novel collaborations to solve systemic problems and improve lives. Together with Intermountain’s 38,000 employees —who are all called caregivers—he has implemented bold new approaches to improve health, re-define value-based care, and serve people in new ways. Intermountain’s partnerships, pioneering initiatives, and commitment to service are transforming healthcare and bearing fruit for patients and communities. Previously, Marc served as CEO of Cleveland Clinic Abu Dhabi, chief of international business development at Cleveland Clinic, and chief medical operations officer. He received his undergraduate degree from Haverford College, his medical degree from Dartmouth Medical School, completed a pediatric residency and pediatric care fellowship at Intermountain’s Primary Children’s Hospital, and a Master of Medical Management at Carnegie Mellon University. He is an all-American triathlete and represented the US at the 2014 World Championships.

Nzinga Harrison, a well-respected physician and educator, is the Chief Medical Officer and Co-Founder of Eleanor Health, an innovative company built on equity and justice that develops mental health medical homes for individuals affected by opioid and other substance use disorders. As host of the In Recovery weekly podcast by Lemonada Media, she engages a large audience on topics related to addiction. As Co-Founder and Vice-Chair of the Board of Physicians for Criminal Justice Reform, Inc., she leads advocacy at the intersection of health and criminal justice. She earned her bachelor’s degree in Biology with Spanish and Chemistry minors at Howard University, completed medical school at the University of Pennsylvania School of Medicine and completed General Psychiatry Residency at Emory University. She is Board-Certified in both Adult General Psychiatry and Addiction Medicine and has spent her career treating individuals with Serious Persistent Mental Illness and Addictive Diseases and advocating for stigma reduction, justice and equity in healthcare. Currently, she holds adjunct faculty appointments at the Morehouse School of Medicine Department of Psychiatry and is Campaign Psychiatrist for Let’s Get Mentally Fit, a public education and stigma-reduction campaign.

Julia Hu founded Lark Health to make healthcare more personal and compassionate through AI. Having managed her own chronic disease her whole life, Julia felt the incredible benefits of 24/7 compassionate care. With health experts and coaches from Stanford, Harvard and artificial intelligence technologists, they developed Lark – a 24/7 personal AI health coach that texts with people to help them manage and prevent chronic disease – anytime, anywhere. A serial entrepreneur, Julia was named in “2015’s Top 10 Women in Tech to Watch” and “30 Under 30” by Inc. Magazine, and "17 Female Healthcare CEOs to Know", Becker's Hospital Review. Previously, Julia ran global startup incubator Clean Tech Open, her own green buildings startup, and was an EIR at Stanford’s StartX. She received her Master’s and Bachelor's degrees from Stanford. Julia is a faculty member at Singularity University, and on the board of the Council of Diabetes Prevention.

Ricardo R. Johnson is Senior Vice President for Corporate Development and leads Healthworx, the innovation and investment arm of CareFirst BlueCross BlueShield (CareFirst). Ricardo is part of a dynamic team that creates, partners with, and invests in companies who are improving affordability, convenience, and equity in healthcare. Ricardo has a deep understanding of the healthcare industry — from product development and operations to strategy and business growth. Before Healthworx, he worked as the Special Assistant to the CEO of CareFirst where he was senior advisor in both strategic and operational functions within CareFirst. Prior to that Ricardo practiced law, including as Associate General Counsel of CareFirst, handling a variety of healthcare and corporate matters. He holds a law degree from University of Maryland and an undergraduate degree from La Salle University.

Jeffrey Kang, MD, has worked in medical groups, commercial health insurance, the federal government and retail health care to bring about changes to improve care for senior patients. He was the first chief medical officer for the Centers for Medicare and Medicaid Services where he was responsible for national coverage decisions, regulation of the healthcare industry, and health plan and provider quality measurement and improvement. As chief medical officer at Cigna, he led the development of several initiatives designed to improve patient care while managing costs. And, as senior vice president of Walgreens health and wellness services and solutions, Jeffrey ran the company’s emerging healthcare businesses. Most recently he was the President of ChenMed a primary care medical group for disadvantaged seniors. He holds a bachelor’s degree from Harvard, a Doctor of Medicine degree from UC San Francisco and a Master’s in Public Health from UC Berkeley. He completed his clinical training at Beth Israel Hospital in Boston and remained on the clinical faculty at Harvard Medical School. Jeffrey currently serves on the board of directors of NCQA (National Committee for Quality Assurance); BlueCross Blue Shield of Minnesota, and ChenMed.

Lynne Katzmann is President and CEO of Juniper Communities, which she founded in 1988 at the age of 32. In 2019, she was the inaugural recipient of McKnight's Women of Distinction Lifetime Achievement Award, and in January 2020 she was inducted into the American Seniors Housing Association Senior Living Hall of Fame. Lynne champions a spirit of innovation and is a firm believer in the double bottom line: doing well by doing good. Under Lynne’s leadership, Juniper developed Connect4Life, a pioneering model of integrated care to position senior living operators to capture their inherent value in the post-acute continuum. This year, Lynne launched Perennial Advantage, an operator-sponsored Medicare Advantage I-SNP, in partnership with Ohio Living and Colorado-based Christian Living Communities. Most recently, Fortune named Juniper to its list of the top 60 Best Places to work in Aging Services. Lynne has held leadership roles in various professional and community organizations, including the Board of Sabra Health, Board of Directors of the Elder Care Alliance, the Executive Board of the American Seniors Housing Association, the Advisory Board of Senior Living 100, the Board of Trustees of Partners for Health, the Board of Advisors of Tufts University Medical School, the Board of the National Investment Center (NIC), and the Secretary and Treasurer on the Board of Trustees of Naropa University. She holds a doctorate in health policy from the London School of Economics.

Vijay Kedar is a passionate leader and skilled executive. Prior to Tomorrow Health, he spent several years helping to scale Oscar Health - leading care management strategy and operations to support chronically ill patients through home-based interventions. He was critical in shaping the success of the company by executing on strategy, financing efforts, network development, medical management, regulatory affairs and more. He is an alum of Harvard College and Harvard Business School and made his way to Oscar after years in Private Equity at Goldman Sachs, where he evaluated $1.1B in investments across healthcare, technology and energy.

Annie Lamont (HC/FT) is a Co-founder and Managing Partner of Oak HC/FT where she focuses on growth equity and early-stage venture opportunities in Healthcare and FinTech. Annie currently serves on the Boards of Advise Health Holdings, Brightline, CareBridge, Clearco, Main Street Health, Oncology Analytics, Quartet, Truepill, Vesta Health, VillageMD and is a Board Observer at Notable. Annie is also actively involved with Blend, Devoted Health, Inscripta, Komodo Health, Precision Medicine Group, and Rubicon Founders. Prior investments include Aspire Health (acquired by Anthem), OODA Health (acquired by Cedar), Poynt (acquired by GoDaddy), athenahealth (NASDAQ:ATHN), American Esoteric Laboratories (acquired by Sonic Healthcare Limited), Argus Information & Advisory Services (acquired by Verisk Analytics), Benefitfocus (NASDAQ: BNFT), CareMedic Systems (acquired by Ingenix), Castlight Health (NYSE: CSLT), CLARiENT (acquired by GE Healthcare), Health Dialog (acquired by British United Provident Association), iHealthTechnologies (merged with Connolly to become Cotiviti), Independent Living Systems, NetSpend (acquired by TSYS), Oak Tree (acquired by Oxford), Odyssey Healthcare, PayFlex Systems (acquired by Aetna), PharMEDium Healthcare (acquired by CD&R), Point Carbon (acquired by Thomson Reuters), Psychiatric Solutions (acquired by Universal Health Services), TxVia (acquired by Google), United BioSource (acquired by Medco Health Solutions) and Vesta Corporation. Annie has appeared on the Forbes Midas List, Institutional Investor’s FinTech Finance 40 list, and the Top 100 Venture Capitalist rankings published by CB Insights and The New York Times. She was the first recipient of the National Venture Capital Association’s award for Excellence in Healthcare Innovation. Annie was also honored with Healthcare Private Equity Association’s 2017 Russell L. Carson Award for lifetime achievement in healthcare investing. Annie serves as a core participant of the Health and Human Services Deputy Secretary’s Innovation and Investment Summit (DSIIS). Annie served on the Stanford University Board of Trustees and also served on the Executive Board of the National Venture Capital Association.

Tom X Lee, MD, is the CEO and visionary behind Galileo — a next-generation health care delivery model designed for the future. Using innovative mobile technology and human-centered design, Galileo is looking to improve the quality and affordability of medical care for all. Prior to Galileo, Tom helped build One Medical into the leading, independent primary care group in the country. In addition, he was responsible for mobile and web products at Epocrates, serving as Chief Medical Officer and lead designer. Tom is a board-certified internist who completed training at Harvard’s Brigham and Women’s Hospital. He received his BS from Yale University, MD from the University of Washington School of Medicine, and MBA from Stanford University’s Graduate School of Business.

Greg Marion joined AARP Services in July 2020 as senior vice president of Health Products and Services, responsible for the strategic direction and growth of the portfolio that represents more than 10 million individual consumer relationships. He brings to the role a long track record of driving profitable growth. His more than 20 years of industry experience includes senior leadership roles at USAA, where he built out the health products business. Greg was previously at Galt & Company consultancy where, as a director, he advised senior executives at Fortune 250 companies. Prior to Galt, Greg spent more than eight years with USAA as vice president of a number of business units. Upon joining, as head of Protection Products, which included life insurance (term and permanent) and health solutions (e.g., Medicare Supplement, long-term care, major medical), he was responsible for approximately $1B in revenue. Then he developed a strategy for a new multi-channel Health Solutions business serving both Medicare-eligible and non-Medicare-eligible customers, which he launched and led, after it was approved by the USAA Board as the organization’s top-five priority. He left USAA as head of its corporate strategy functions (Enterprise Strategy, Competitive Intelligence, Experience Strategy and Planning). He has a Master’s in Business Administration from the University of Chicago’s Booth School of Business and a Bachelor of Arts with Honors from the University of Michigan.

As HealthSparq’s General Manager, Mark leads the company’s strategic direction, ensuring the company is living its mission of helping people make smarter healthcare choices, while working in partnership with leading health plans in the US. Mark brings more than 23 years of experience in the software and healthcare fields, and has a proven track record of innovation, leadership and driving client satisfaction. In 2014 HealthSparq acquired ClarusHealth, where Mark served as CEO and led the transformation of the business into one of the first major areas for healthcare transparency: provider search. Today, HealthSparq delivers healthcare cost transparency, provider search, shopping incentives programs and other critical tools to more than 80 million health plan members nationwide.

Nate Murray is an entrepreneur with a strong passion for healthcare and more than 10 years of experience in the industry. He is an active member in the Health 2.0 movement, has worked for several large healthcare payers in operations and product development, and has experience in partner and consumer marketing, call center operations, and strategic planning. He has also worked in healthcare technology, helping payers and consumers understand and make important decisions based on costs. Most recently, Nate led the development of a direct-to-consumer Medicare marketing program, and he is credited with building the largest online Medicare partner network. As Chief Business Development Officer with Crossover Health, Nate works closely with the procurement, finance, and benefits design teams to ensure administrative and financial compliance of the health services implemented. Nate also helps to develop shared savings programs that align incentives across the partnership, and deliver objective improvements along the cost, quality, and experience dimensions. Nate earned his Bachelor of Arts in Economics from the University of Utah and holds a Master of Business Administration degree from Brigham Young University. He lives in Laguna Niguel with his wife and sons, and enjoys basketball, surfing, and spending time with his family.

Dan Olson serves as SVP of Provider Solutions at Amwell where he leads a team focused on hospital and health system sales, account management, implementation, and solution design. In his role, Dan is a valued partner to provider organizations of all sizes, helping leadership teams to develop or optimize their telehealth strategy. Dan’s past experience includes leadership roles in the areas of healthcare technology, life sciences and medical devices. Dan spent 25 years working in Fortune 50 organizations – Johnson & Johnson, Merck and Cisco Systems as well as within start-up companies such as Ash Access Technology and Bone Care International. Throughout his career, Dan has utilized his experiences to consummate favorable commercial agreements, increase revenue and market share, enhance and expand customer relationships and develop the organizations’ human resource talent. Dan graduated from the University of Wisconsin School of Business.

Marcus Osborne serves as Senior Vice President, Walmart Health, where he is focused on furthering Walmart’s goal of providing quality healthcare that is affordable and accessible. Walmart Health is a first of its kind health center that provides integrated care of key health services like primacy care, dental, counseling and diagnostics all under one roof with affordable and transparent pricing. Prior to joining Walmart, Marcus was a Senior Management Consultant with Alliance Consulting Group in Boston, Massachusetts. He also served as the Chief Financial Officer of the Clinton Foundation HIV/AIDS Initiative. Marcus attended the Harvard Business School and received his Master’s in Business Administration, graduating with honors.

Cheryl Pegus, MD, MPH is Walmart’s executive vice president of Health and Wellness. In this role, Cheryl will develop Walmart’s bold healthcare vision, leading Health and Wellness across the Walmart enterprise. She joins Walmart from Cambia Health Solutions where she was president of consumer health solutions and chief medical officer. There she was responsible for clinical and consumer strategy to increase access to affordable, equitable care. She directed platform consumer solutions including Journi, clinical services, pharmacy, provider and medical management activities. After working in private practice for several years as a cardiologist, Cheryl joined Pfizer where she focused on the development of clinical protocols and early disease management programs. She also served at Aetna, where her work supported a focus on wellness, women's health, health equity initiatives and predictive analytics. Cheryl served as the first chief medical officer at Walgreens. Additionally, Cheryl is co-founder of A New Beat, an organization dedicated to improving the cardiovascular health and careers of women and under-represented minorities. She sits on the board of the American Heart Association and is the immediate past board chair for the Association of Black Cardiologists. Cheryl received her bachelor’s degree from Brandeis University. Her medical doctorate is from Weill Cornell Medical College, and she has a master’s degree in Public Health from Columbia University Mailman School of Public Health.

Alex Petrov is the Founder and CEO of Yes Health. Alex has a background in consumer products, retail and technology experiences launching new businesses, building global consumer brands and leading high performance teams. Alex's career has spanned roles such as PayPal's VP of Retail Marketing launching mobile wallet into offline and online retailers; President of Lucerne Foods/Safeway, growing a $7 billion consumer brands portfolio including O Organics and Eating Right, and Nestlé as Head of Dairy Beverage Brands. He started Yes Health from his own personal experience after being diagnosed with prediabetes and his father having Type 2 diabetes.

Hoangmai (Mai) H. Pham, MD MPH is a general internist and national health policy leader. She was Vice President, Provider Alignment Solutions at Anthem, Inc., responsible for value-based care initiatives at the country’s second largest health insurance company. Prior to Anthem, she served as Chief Innovation Officer at the Center for Medicare and Medicaid Innovation, where she was a founding official, and the architect of Medicare’s foundational programs on accountable care organizations and primary care. She was Co-Director of Research at the Center for Studying Health System Change and has published extensively in the medical literature on provider payment policy and its intersection with health disparities, care coordination, quality performance, provider behavior, and market trends. She serves on numerous advisory bodies, including the National Advisory Council for the Agency on Healthcare Research and Quality, the Maryland Primary Care Program, and the National Business Group on Health, and was a member of the Board Executive Committee at the Health Care Transformation Task Force. She is an Adjunct Fellow at the Leonard Davis Institute of Health Economics of the University of Pennsylvania, and Faculty at the Institute for Healthcare Improvement. She earned her AB from Harvard University, her MD. from Temple University, and her MPH from Johns Hopkins University where she was also a Robert Wood Johnson Clinical Scholar.

Joanne Pike, DrPH, is the chief strategy officer of the Alzheimer’s Association®. In this role she oversees the Association’s strategic plan to advance risk reduction, care and support, research, advocacy, diversity and inclusion, concern and awareness, and fundraising. She oversees care and support services offered across the organization to those affected by the disease; outreach aimed at creating partnerships with health systems, physicians and other health care professionals; long-term care initiatives focused on person-centered care delivery models; and growth strategies for reaching more individuals through quality improvement, education, and supportive programs and services. Joanne is responsible for guiding the implementation of the Association’s Dementia Care Practice Recommendations, which establish a new foundation in quality care for individuals living with Alzheimer’s and other dementias. The product line — which includes essentiALZ® certification and curriculum review — are designed to train professional care providers to deliver high-quality, person-centered care to people living with Alzheimer’s and other dementias. Throughout her career, she has successfully leveraged public policy to advance such public health outcomes with a particular emphasis on outreach to diverse communities. Prior, she spent 13 years in leadership positions at the American Cancer Society and three years as executive director of the Preventive Health Partnership, a collaboration between the American Cancer Society, the American Diabetes Association and the American Heart Association aimed at preventing cancer, diabetes, heart disease and stroke. She has a doctorate in public health leadership, focused on health policy and management, from the University of North Carolina at Chapel Hill.

Aimee Quirk is the CEO of innovationOchsner (iO), an innovation company founded by Ochsner Health in 2015 to reimagine and revolutionize the delivery and experience of healthcare and health, with a focus on digital health, advanced analytics and personalized medicine. iO has developed several award-winning programs, including Ochsner Digital Medicine, Connected MOM and Optimal Hospital. It has also developed several innovative partnerships and launched new tools including multiple AI predictive models for clinical and operations applications and population genomics. Aimee joined iO in 2015 with more than 15 years of experience in law, economic development and public affairs. Previously, she served as the Senior Advisor for Economic Development for New Orleans Mayor Mitch Landrieu from 2010 to 2014. Prior to her public service, she was a partner at Jones Walker, where she practiced corporate and business litigation. She received a BS in Finance magna cum laude from Louisiana State University and a J.D. summa cum laude from Tulane University School of Law. She has been recognized by Becker’s among the Women to Watch in Health IT and participates in multiple healthcare innovation advisory boards and networks. A native of New Orleans, she is active in the community and serves on several boards, including GNO, Inc., the Association for Corporate Growth and the Center for Resilience.

Peter A. Rasmussen, MD, currently serves as the Chief Clinical Officer for CCAW JV, and is a Professor of Neurosurgery in the Cerebrovascular Center/Department of Neurosurgery at the Cleveland Clinic in Cleveland, Ohio. He is the former Medical Director of Digital Health at the Cleveland Clinic where he oversaw the Clinic’s overall digital health strategy and implementation of their digital medical platforms. This included the Clinic’s flagship virtual care service “Express Care Online”, as well as site-to-site services and virtual chronic disease management services. He maintains a busy clinical practice offering patients either open microsurgery or endovascular, minimally invasive treatment options. As the former Director of the Cerebrovascular Center at the Cleveland Clinic, he founded the Clinic’s telestroke program which has grown to ~2000 teleconsults/year, and he envisioned and implemented the Clinic’s Mobile Stroke Treatment Unit, one of the first two units in the US. He is a Past-President of the Society of Neurointerventional Surgery, and enjoys international recognition as a cerebrovascular surgery expert. He is a graduate of the University of Wisconsin Medical School in Madison, Wisconsin, completed fellowship training in interventional neuroradiology/endovascular neurosurgery at the Cleveland Clinic Foundation, as well as a fellowship in microsurgical treatment of cerebrovascular disease also at the Cleveland Clinic. A recognized innovator and KOL of both digital medicine and endovascular neurosurgery, he is past Vice Chair of the American Association of Neurological Surgeons/Congress of Neurological Surgeons, Cerebrovascular Section, and has been appointed as a fellow of the American Heart Association (FAHA), the American Association of Neurological Surgeons (FAANS), and a founding fellow of the Society of Neurointerventional Surgery (FSNIS).

Monique Reese, DNP, ARNP, FNP, ACHPN, is the senior vice president of home and community care for Highmark Health, an $18 billion national, blended health organization that includes one of America’s largest Blue Cross Blue Shield insurers and a growing regional hospital and physician network. Based in Pittsburgh, Pa., Highmark Health’s 35,000 employees serve millions of customers nationwide through the nonprofit organization’s affiliated businesses including Highmark Inc., Allegheny Health Network, HM Insurance Group, United Concordia Dental, HM Health Solutions and Helion. Monique is responsible for leading the transformation of Highmark Health’s long-term post-acute strategy, including oversight of Helion and Allegheny Health Network Healthcare@Home. She has extensive experience leading strategies focused on population health in both fee-for-service and value-based health environments. Prior to joining Highmark Health in 2018, Monique served as chief clinical officer for Sutter Health, overseeing Sutter Care at Home’s operations and clinical practice including the back-office areas of compliance, education, and quality. She was also the chief clinical officer for the ambulatory enterprise at UnityPoint Health, where she developed and implemented the pre- and post-acute strategy. Monique is also a family nurse practitioner with a subspecialty in palliative care and hospice. Her nursing background includes experience in family practice, community health, school nursing, post-secondary education, medical-surgical, orthopedics, palliative care and hospice.

As Founder and CEO of Wellist, Ashley combines her passion for improving the lives of patients with deep experience in digital health, strategy and consumer marketing. Following her tenure at Philips Healthcare, The BridgeSpan Group and Bain and Company, Ashley founded Wellist in 2013 to manage gaps in support for individuals and their families as they navigate their unique healthcare journeys. Wellist addresses whole-person care with hyper-local, clinically tailored consumer programs to improve health equity, loyalty and revenue. Today, Wellist programs support patients in all service lines and in over 20 markets across the United States. Wellist’s outstanding contributions have been recognized by organizations including MassTLC (Most Innovative Technology of the Year – Healthcare) and Rock Health (Top 50 in Digital Health honoree, Diversity Leadership). Ashley has also been recognized as one of Med Tech’s 40 under 40 Healthcare Innovators.

Fay Rotenberg is the President and CEO of Firefly Health, a virtual-first primary care, behavioral health, and specialty care company that is launching a ‘care + coverage’ health plan offering (a ‘virtual-first Kaiser’) to provide half-priced healthcare that is twice as good, clinically and emotionally. Fay brings dynamic experience as a Healthcare Founder, CEO, Venture Investor, and Developer to this role. Previously, Fay worked with Premji Invest to initiate their U.S. healthcare growth equity investments. Fay co-founded and served as CEO of Mymo, a healthcare technology company that bridges the gap between excess physician capacity and patient demand. Before co-founding Mymo, Fay was a Partner at LG's venture fund where she invested in health and enterprise software companies. She also led the first spin-off of AetherWorks, a software-defined storage solution for healthcare organizations. Fay attended Georgetown University and Phillips Academy Andover. She’s actively involved as an Advisor or Board Member of Cornell Tech, Phillips Academy Andover, Masschallenge, Girls Who Code, and the Young Presidents Organization (YPO).

Marc Rothman, MD oversees clinical quality and program development for Signify Health. Prior to this, Dr. Rothman served as Deputy Chief Medical Officer at Aspire Healthcare, where he led a nationwide palliative care medical practice and implemented and grew new clinical models and business lines. He also served as Enterprise Chief Medical Officer at Kindred Healthcare, where he oversaw medical affairs, clinical quality, patient experience, and pharmacy services. Dr. Rothman holds an MD from New York University School of Medicine and is triple boarded in internal, geriatric, and hospice & palliative medicine.

Amir Dan Rubin serves as Chair, CEO, and President of One Medical, the leading member-based primary care organization transforming health care with its human-centered, technology-powered model. Amir previously served as EVP at UnitedHealth Group’s Optum division, where he focused on making the health system work better. Amir also previously served as President and CEO at Stanford Health Care—the academic health system affiliated with Stanford University—where he helped raise patient experience and quality scores to the highest levels in the nation, grow a regional network, and advance digital and population health. Amir also previously served as COO for UCLA Health, COO for Stony Brook University’s health system, AVP at Memorial Hermann Health System, and management consultant at APM. He holds MBA and MHSA degrees from the University of Michigan, a BA from the University of California, Berkeley, and has twice received an EY Entrepreneur of the Year award.

Suchi Saria, PhD, is the Founder and CEO of Bayesian Health, the John C. Malone endowed chair and Associate Professor of Computer Science, Statistics and Health Policy, and the Director of the Machine Learning and Healthcare Lab at Johns Hopkins University. Her research has pioneered the development of next generation diagnostic and treatment planning tools that use statistical machine learning methods to individualize care. She has written several of the seminal papers in the field of ML and its use for improving patient care and has given over 250 invited keynotes and talks to organizations including the NAM, NAS, and NIH. Suchi serves as an advisor to several Fortune 500 companies and her work has been funded by leading organizations including the FDA, NSF, DARPA and CDC. In 2020, she was invited to deliver a TEDMED keynote entitled "Bringing AI to the Bedside," discussing the opportunity for AI in the healthcare setting to save lives. At Bayesian Health, she is operationalizing her decades of research in the field to make healthcare proactive by empowering physicians, nurses, and care team members with real-time data to save lives. Learn more at bayesianhealth.com. Suchi has been featured in Bloomberg News and PBS NOVA and she has won several awards for excellence in AI and care delivery, including IEEE’s “AI’s 10 to Watch”, MIT Tech Review’s “35 Under 35”, DARPA’s List of Rising Stars, World Economic Forum’s 100 Brilliant Minds Under 40, The Armstrong Award for Excellence in Quality and Safety; Node.Health’s Best in Class Digital Health Intervention Award; and Society of Critical Care Medicine’s Annual Scientific Award.

Simeon serves as the CEO of Bright HealthCare. He is a healthcare industry veteran with broad experience and demonstrated success in senior executive roles. At Bright HealthCare, Simeon oversees the insurance line of business. Before Bright HealthCare, Simeon served as founder and CEO of CreateHealth Plans and CEO of MagnaCare. Create, a Brighton Health Plan Solutions business, combines health care delivery system competition with full alignment of the interests of patients/families, providers, and employers and therefore drives lower cost and higher-quality health care with optimal patient experience. Prior to CreateHealth Plans, Simeon served as chairman and CEO of Bloom Health, a Minneapolis-based leader in designing, building, and operating private exchanges. He has also held senior level executive management positions at several high-profile healthcare companies including Medica Health Plans and UnitedHealth Group. Simeon currently serves as an advisor to JLL Partners and on the IBM Watson Health Payor Advisory Council. Simeon holds a Bachelor of Arts in mathematics and economics from Dartmouth College.

Mario Schlosser is the CEO and co-founder of Oscar, a leading insurer built to make health care easy. Under his leadership, Oscar develops seamless technology and provides personalized support to help more than 540,000 members navigate their health care. Oscar has been recognized as one of Fast Company’s most innovative companies in health, one of CNBC’s top 50 disruptors, and one of TIME’s most influential in health care. Previously, he co-founded the largest social gaming company in Latin America, where he led the company's analytics and game design practices. Prior to that, Schlosser was a Senior Investment Associate at Bridgewater Associates and worked as a consultant for McKinsey & Company in Europe, the U.S. and Brazil. Schlosser also spent time as a visiting scholar at Stanford University, where he wrote and co-authored 10 computer science publications, including one of the most-cited computer science papers published in the past decade, in which he developed the EigenTrust Algorithm to securely compute trust in randomized networks. In May 2019, Schlosser and his co-authors, Sepandar D. Kamvar (Mosaic Building Group Inc) and Héctor Garcia-Molina (Celo), received the prestigious Seoul Test of Time Award from the International World Wide Web Conference Committee (IW3C2) for this work. Schlosser holds a degree in computer science with highest distinction from the University of Hannover in Germany and an MBA from Harvard Business School.

Ashley Smith is a Partner in Oliver Wyman’s Health and Life Sciences practice, based in San Francisco. She focuses on advising payers, health systems, pharmaceutical companies and retailers on forming unique partnerships to capture value in the changing healthcare market. Prior to Oliver Wyman, Ashley was an associate in the Strategy and Corporate Development group at Mercer, the world’s leading provider of HR and related financial services, where she supported global business strategy, new offer development, merger, acquisition, and divestiture activities. In addition, she spent time at Booz & Company and Keefe, Bruyette & Woods. Ashley received a BS in business administration, BA in economics (honors), and a BA in English literature from the University of California, Berkeley where she was also a member of Cal’s Pac-10 and NCAA-champion women’s rowing team.

Glen Tullman is the Executive Chairman and Chief Executive Officer of Transcarent, the first comprehensive, consumer-directed health and care platform for employees of self-insured employers and their families. Born in Silicon Valley, Transcarent’s platform empowers consumers with the kind of information, guidance and access that leads to better care, better outcomes, and more cost-effective decisions for everyone. Tullman is the former Executive Chairman, Chief Executive Officer, and Founder of Livongo Health, the first at-scale consumer digital health company to truly empower people with chronic conditions to live better and healthier lives using data science. In his final year, he led Livongo through the largest consumer digital health Initial Public Offering in history, a secondary offering, a convertible debt offering that raised over $550 million, and the industry’s largest merger to date between Livongo and Teladoc Health, valuing Livongo at $18.5 billion and beginning a new era of consumer centric virtual care. A visionary leader and entrepreneur, Tullman previously ran two other public companies that changed the way health care is delivered. During his time as Chief Executive Officer of Allscripts, the Company was the leading provider of electronic prescribing, practice management, and electronic health records. Glen led Allscripts IPO and Secondary offerings. Prior to Allscripts, he was Chief Executive Officer of Enterprise Systems, the leading resource management systems for hospitals, which he also took public and then sold to McKesson/HBOC. Before entering healthcare, Tullman served as President and COO of CCC Information Systems, a provider of computerized systems for the property and casualty insurance sector. Tullman is also one of two Founding Partners at 7wireVentures, one of the highest returning venture capital funds in Illinois. He is the author of On Our Terms: Empowering the New Health Consumer, in which he proposes new solutions to address the chronic-condition epidemic facing our country. Glen is dedicated to finding a cure for diabetes and other chronic conditions—and to keeping people healthy until cures are found. A strong proponent of philanthropy, he was honored in 2019 with a Robert F. Kennedy Human Rights Ripple of Hope Award for his career focused on improving the safety, empathy, and efficiency of our healthcare system. He also serves as a Chancellor to the International Board of the Juvenile Diabetes Research Foundation and as a Board Member and the incoming Chairperson of the American Diabetes Association. Tullman has three amazing children that inspire him every day.

Sara Vaezy is the Chief Digital and Growth Strategy Officer for Providence leading digital strategy and roadmap, digital partnerships and business development, commercialization, technology evaluation and pilots and digital thought leadership as a part of the Providence Digital Innovation Group. Prior to Providence, Sara was at The Chartis Group, a health care management consulting firm, where she advised clients on enterprise strategic planning, payer-provider partnership, and the development of population health companies. She holds a BA in Physics and Philosophy from the University of California Berkeley, and an MHA and MPH in Healthcare Policy from The University of Washington’s School of Public Health.

Robbert Vorhoff is a Managing Director and Global Head of General Atlantic’s Healthcare sector. He also serves on the firm’s Management Committee. Robb joined GA in 2003 and is based in the firm’s New York Office. He currently serves as a member of the board of directors for Alignment Healthcare, Alternate Solutions Health Network, Doctor on Demand, Equality Health, Marathon Health, Oak Street Health, OneOncology and Vida Health. Previous portfolio responsibilities have included A Place for Mom, eviCore Healthcare, Landmark Health, MedExpress Urgent Care, Align Networks, Grupo Qualicorp, RiskMetrics Group, and NYSE Euronext. Before joining the firm, Robb worked at Greenhill & Co., first in the mergers & acquisitions and restructuring advisory group, and then in the private equity group, Greenhill Capital Partners, where he focused on investments in financial services, energy, and education.

As CEO of Evernorth, Cigna Corporation’s dynamic $100B+ health services portfolio, Tim Wentworth brings together the vast array of Evernorth’s health services capabilities, along with those from partners across the health care system in pharmacy solutions, benefits management, care solutions, and data and analytics. Prior to this role, Tim served as president, Express Scripts and Cigna Services, where he led a broad range of pharmacy services, including benefits management and specialty pharmacy services. Prior to Cigna’s acquisition of Express Scripts in 2018, Tim served as president and CEO of Express Scripts, where he championed better healthcare by aligning with plan sponsors, taking on tough challenges and delivering patient-centered care. During his earlier tenure at Medco, which combined with Express Scripts in 2012, he led the employer and key accounts organizations. He also served as President and CEO of Accredo, the company’s specialty pharmacy. He previously held leadership positions at Mary Kay Inc. and Pepsi Co. A leader in his field, Tim serves as a director of the Columbia University Health Policy & Management National Advisory Board; a trustee of Columbia University teachers college; a trustee of the University of Rochester (New York); a member of the American Heart Association CEO Roundtable; a director for Civic Progress (St. Louis); a director of Concordance Academy of Leadership (St. Louis); and a director of the Opera Theatre of Saint Louis. He is also an active signatory to the CEO Action for Diversity & Inclusion pledge. Tim earned a bachelor’s degree in industrial and labor relations from Cornell University and an associate’s degree in business from Monroe Community College. He received an honorary doctorate degree from the State University of New York.

George Whitesides is the Chairman of the Space Advisory Board for Virgin Galactic, a human spaceflight company founded by Richard Branson. Whitesides was the first CEO of the company, growing the company over a decade from a small team to the global aerospace firm it is today. Under Whitesides' leadership, the company flew the first human spaceflight from US soil since the retirement of the Space Shuttle, flew the first woman to space on a commercial space vehicle, and took the company public on the NYSE. Prior to Galactic, he worked on President Obama's transition team, and subsequently served as NASA Chief of Staff for NASA Administrator Charlie Bolden. Whitesides was awarded the Distinguished Service Medal, NASA's highest honor, upon his departure in 2010. Whitesides has testified on American space policy before the United States Senate, the United States House of Representatives, and the President’s Commission on Implementation of United States Space Exploration Policy. He serves on a variety of philanthropic councils and boards, including Caltech's Space Innovation Council, Princeton's Advisory Council for Mechanical and Aerospace Engineering, and the advisory board for the Alliance for SoCal Innovation. He serves as a mentor for the Brook Owens Fellowship program, for increased representation of female leadership in the aerospace industry, and helped start the BLAST scholarship program to mentor Black aerospace student-leaders, in partnership with UNCF. He did his undergraduate degree in Public and International Affairs at Princeton University, an MPhil in GIS and Remote Sensing at Cambridge University, and a Fulbright Scholarship in Tunisia.

Ian Wijaya is a Managing Director in Lazard’s Healthcare Group in New York and leads Lazard’s Healthcare Services practice. Ian joined Lazard in 2011 and co-founded the Firm’s healthcare services practice, with a focus on M&A, strategic advisory and recapitalization advisory for managed care insurance payers, providers across the continuum of care (e.g., acute care hospitals, ambulatory surgery centers, post-acute care, etc.), PBMs, distributors, payor and provider services companies, and HCIT/digital health companies. Ian is a member of Lazard’s Opinion Committee. Ian is a member of the World Economic Forum’s Global Future Council on Healthcare, as well as a Corporate Leader on the Council on Foreign Relations. Prior to Lazard, Ian was an investment banker at Greenhill & Co., in New York, where he focused on healthcare M&A, but also provided M&A advice to companies in the technology and retail sectors. Prior to Greenhill & Co., he worked in the Investment Banking Division of Goldman, Sachs & Co. and the financial restructuring group of Houlihan Lokey, in New York.

Julie Yoo is a General Partner at Andreessen Horowitz where she leads investments in healthcare technology, with a focus on companies that are modernizing how we access, pay for, and experience the healthcare system. Prior to joining a16z, Julie was the co-founder, Chief Product Officer, and Board Director at Kyruus, a venture-backed healthtech company recognized as a market leader in patient access. Julie led product management, engineering, and sales and marketing for the company, and helped scale the business to reach 20M patients and over 225,000 healthcare providers across the U.S. Julie was previously VP of Product at Generation Health, and was with the company from its inception through acquisition by CVS Health. Julie was also a Product Manager at Knome, the world's first whole genome sequencing service for private individuals. Julie’s tech career began as an early member of the software engineering team at Endeca Technologies, which was acquired by Oracle. Julie studied computer science and pre-medicine as an undergrad at MIT and obtained an MS in genomics from Harvard-MIT HST and an MBA from MIT Sloan. Julie is a Young Global Leader with the World Economic Forum and has been recognized through numerous awards and honors from Becker’s Hospital Review, Health Data Management, MedTech Boston, and Rock Health. Julie serves on a number of portfolio company boards, including Akasa, Firefly Health, Ribbon Health and Tomorrow Health.